Hutchmed (china) Share Discussion Threads

[mcmather] 14/7/2021 14:50

And one who is based in HK; RNS appears to have been after the close in HK so possible positive reaction overnight.

[cockneytrader] 14/7/2021 14:41

Billionaire takes 3% stake.

[dbadvn] 13/7/2021 09:57

HM is going to be flooded with cash over the next few years . That is what will overcome the ‘Chinese Company’, lack of takeover premium etc and drive the share price.

[whatja] 13/7/2021 07:48

Good for AZN…..not hanging around.
30% to HCM straight to bottom line.

[lauders] 13/7/2021 05:28

Some good news from HCM under the announcements tab over on the HKEX:

VOLUNTARY ANNOUNCEMENT – First Commercial Sale of ORPATHYS®in China, Triggering a US$25 million Milestone Payment from AstraZeneca

HUTCHMED (China) Limited (“HUTCHMED”) announcesthe first commercial sale in China of ORPATHYS®(savolitinib), HUTCHMED’s oral, potent, and highly selective small molecule inhibitor of MET, a receptor tyrosine kinase, which occurred on July 12, 2021.

[steeplejack] 08/7/2021 09:17

533p HK close

[nahoon] 06/7/2021 19:34

hxxps://www.wsj.com/articles/china-to-revise-rules-and-strengthen-supervision-of-overseas-listings-11625572533?st=l523pvukowp10om&reflink=desktopwebshare_permalink

Probably scared the US listing, now down 14%. Long sigh....

[dbadvn] 06/7/2021 18:04

Trading volume will be dominated by HK and eventually Shanghai in any case.

[nerdofsteel] 06/7/2021 17:48

They have already suffered. As an example I have a 401K and the rules of the scheme specifically prohibit the Fund Managers from investing in any Chinese Companies.

[steeplejack] 06/7/2021 15:49

Well,you’re right.

What an irritating stock this is to hold.


“China said it would tighten rules for com­pa­nies seek­ing to sell shares abroad and strengthen over­sight of over­seas-listed com­pa­nies, moves that could hin­der at­tempts by home­grown firms to raise money in the U.S.”WSJ 6th July 2021

This news today in the Wall St Journal is the start of an article discussing the increasing tensions between the US and China.Its probable that Hutchmed decided to get on with an HK listing in awareness that life could become much more difficult for Chinese companies wanting to raise money in the US,especially for tech companies,not just because of US moves but because of moves by the Chinese Government.If things get worse,Chinese companies could find a lack of US investor appetite for the equity of Chinese listed companies.Yet,happily,the recent HK listing of Hutchmed attracted excellent North American backing but going forward things might not be so benign.

[fionascott1234] 06/7/2021 13:59

Oh really?Well no surprise that it will finish sub-£5 here then.

[lauders] 06/7/2021 12:23

Updated Trinity Delta valuation of 802p now.

US$52.12/ADS or 802p/HK$81.30/share valuation Following the Hong Kong IPO and global offering, and recent China approvals of surufatinib (pNET) and savolitinib (NSCLC MET ex14m), our updated HUTCHMED valuation is US$8.84bn (US$52.12 per ADS), £6.8bn (802p per share), or HK$69.0bn (HK$81.30 per share). Details are available in our July 2021 Update. Clinical, regulatory, and commercial progress and the planned expansion of the clinical pipeline could unlock further value.

[steeplejack] 06/7/2021 07:32

HK closed at 521p equiv.

[lauders] 06/7/2021 04:25

HUTCHMED Initiates Phase I Trials of novel ERK inhibitor HMPL‑295 in Patients with Advanced Solid Tumors in China

[steeplejack] 05/7/2021 09:13

553p close in HK

[miti 1000] 05/7/2021 09:03

Well got my timing totally right, for once, buying hcm on the dip. Happy to have sold up here on the HK ipo.

[mcmather] 02/7/2021 12:36

That is a big chunk acquired by The Carlyle Group Inc.

[fionascott1234] 02/7/2021 08:30

Agreed.I wonder where the MM s keep their bag of numbers to manipulate the HCM price particularly that of the closing price.

[steeplejack] 02/7/2021 07:41

Hopefully,the HK market (trading until 9am UK time)will steady the UK AIM quote,The AIM marketmakers behave like masked feral youths looking to mug the unwary with wide spreads and inexplicable volatility.Really irritates albeit the thinness of trading in the UK provides some excuse.HK holding around £6 equivalent.

[nerdofsteel] 02/7/2021 07:06

currently trading at £6.07 equivalent, went as high as £6.73 shortly after opening. As predicted, a proper valuation more equivalent to Innovent.

[dbadvn] 01/7/2021 19:23

Next time we see CH I think at least “we told you so” is in order and probably more.

Let’s hope he has got the message and gets on with a Shanghai listing pronto.

[yidarmytom] 01/7/2021 18:17

great progress here

[its the oxman] 01/7/2021 00:37

Back over 600p then, soon hopefully.